CUE Cue Biopharma, Inc.
Healthcare$20.03-6.71%ClosedMarket Cap: $52.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.78
P/S
1.72
EV/EBITDA
-2.75
DCF Value
$-161.15
FCF Yield
-43.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
99.8%
Operating Margin
-59.8%
Net Margin
-59.6%
ROE
-98.3%
ROA
-63.2%
ROIC
-78.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.7M | 100.0% | $-5.4M | $-5.2M | $— | — |
| Q4 null | $21.9M | 100.0% | $2.0M | $1.6M | $— | — |
| FY null | $27.5M | 100.0% | $-26.5M | $-26.6M | $— | — |
| Q3 null | $2.1M | 96.3% | $-7.5M | $-7.4M | $— | — |
| Q2 null | $3.0M | 100.0% | $-8.6M | $-8.5M | $— | — |
| Q1 null | $421.0K | 100.0% | $-12.3M | $-12.3M | $— | — |
| Q4 null | $1.6M | 100.0% | $-9.6M | $-9.5M | $— | — |
| FY null | $9.3M | 100.0% | $-41.5M | $-40.7M | $— | — |
| Q3 null | $3.3M | 100.0% | $-8.8M | $-8.7M | $— | — |
| Q2 null | $2.7M | 100.0% | $-10.4M | $-10.2M | $— | — |
| Q1 null | $1.7M | 100.0% | $-12.7M | $-12.3M | $— | — |
| Q4 2023 | $1.8M | -640.6% | $-13.8M | $-13.4M | $-0.28 | — |